Congenital Adrenal Hyperplasia Epiomic Epidemiology Forecast In 31 Major Markets 2018-2028 - ResearchAndMarkets.com

September 17, 2018

DUBLIN--(BUSINESS WIRE)--Sep 17, 2018--The “Congenital Adrenal Hyperplasia Forecast In 31 Major Markets 2018-2028” report has been added to ResearchAndMarkets.com’s offering.

Congenital adrenal hyperplasia (CAH) is a group of genetic disorders associated with deficiencies of several adrenal enzymes which lead to abnormal production of glucocorticoids, mineralocorticoids and sex steroids. This, in turn, affects metabolism, sodium and water balance and the development of primary or secondary sex characteristics. CAH can occur in classic (severe) or non-classic (mild) forms depending on the amount of residue enzyme activity. This report covers only the classic form of the disorder.

This report provides the current prevalent population for CAH across 31 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, Netherlands, Belgium, Norway, Sweden, Denmark, Austria, Switzerland, Ireland, Czech Republic, Hungary, Romania, Croatia, Russia, Turkey, Egypt, Japan, China, South Korea, India, Australia, Brazil, Mexico, Argentina) split by gender and 5-year age cohort. In addition to the current prevalence, the report provides an overview of the risk factors, diagnosis and prognosis of the disease, along with specific variations by geography and ethnicity.

Main symptoms and co-morbidities of CAH include:

Hypertension, hyperlipidaemia, diabetes and venous thromboembolism Osteoporosis/osteopaenia Growth impairment and short stature Infertility Respiratory and gastrointestinal infections

Key Topics Covered:

List Of Tables And Figures Introduction Cause Of The Disease Risk Factors & Prevention Diagnosis Of The Disease Variation By Geography/Ethnicity Disease Prognosis & Clinical Course Key Comorbid Conditions / Features Associated With The Disease Methodology For Quantification Of Patient Numbers Top-Line Prevalence For Congenital Adrenal Hyperplasia Features Of Congenital Adrenal Hyperplasia Patients Abbreviations Used In The Report Other Publisher Services & Solutions Reports & Publications Online Epidemiology Databases Online Pharmaceutical Pricing Database References Appendix For more information about this report visit https://www.researchandmarkets.com/research/r3ss85/congenital?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20180917005572/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 09/17/2018 12:49 PM/DISC: 09/17/2018 12:49 PM


Update hourly